159 related articles for article (PubMed ID: 9184910)
1. HLA-G functions as a restriction element and a transplantation antigen in mice.
Horuzsko A; Antoniou J; Tomlinson P; Portik-Dobos V; Mellor AL
Int Immunol; 1997 May; 9(5):645-53. PubMed ID: 9184910
[TBL] [Abstract][Full Text] [Related]
2. Cell-surface expression and alloantigenic function of a human nonclassical class I molecule (HLA-E) in transgenic mice.
Pacasova R; Martinozzi S; Boulouis HJ; Ulbrecht M; Vieville JC; Sigaux F; Weiss EH; Pla M
J Immunol; 1999 May; 162(9):5190-6. PubMed ID: 10227992
[TBL] [Abstract][Full Text] [Related]
3. CD8+ T cells are necessary for recognition of allelic, but not locus-mismatched or xeno-, HLA class I transplantation antigens.
Borenstein SH; Graham J; Zhang XL; Chamberlain JW
J Immunol; 2000 Sep; 165(5):2341-53. PubMed ID: 10946256
[TBL] [Abstract][Full Text] [Related]
4. Maturation of antigen-presenting cells is compromised in HLA-G transgenic mice.
Horuzsko A; Lenfant F; Munn DH; Mellor AL
Int Immunol; 2001 Mar; 13(3):385-94. PubMed ID: 11222508
[TBL] [Abstract][Full Text] [Related]
5. Cytotoxic T lymphocyte recognition of HLA-G in mice.
Schmidt CM; Garrett E; Orr HT
Hum Immunol; 1997 Jul; 55(2):127-39. PubMed ID: 9361964
[TBL] [Abstract][Full Text] [Related]
6. Recognition of xeno-(HLA, SLA) major histocompatibility complex antigens by mouse cytotoxic T cells is not H-2 restricted: a study with transgenic mice.
Kievits F; Wijffels J; Lokhorst W; Ivanyi P
Proc Natl Acad Sci U S A; 1989 Jan; 86(2):617-20. PubMed ID: 2783490
[TBL] [Abstract][Full Text] [Related]
7. HLA-restricted recognition of viral antigens in HLA transgenic mice.
Kievits F; Ivanyi P; Krimpenfort P; Berns A; Ploegh HL
Nature; 1987 Oct 1-7; 329(6138):447-9. PubMed ID: 2821399
[TBL] [Abstract][Full Text] [Related]
8. HLA-G transgenic mice.
Mellor A; Zhou M; Conway SJ; Munn D
J Reprod Immunol; 1999 Jul; 43(2):253-61. PubMed ID: 10479061
[TBL] [Abstract][Full Text] [Related]
9. Immunological function of HLA-C antigens in HLA-Cw3 transgenic mice.
Dill O; Kievits F; Koch S; Ivanyi P; Hämmerling GJ
Proc Natl Acad Sci U S A; 1988 Aug; 85(15):5664-8. PubMed ID: 2840670
[TBL] [Abstract][Full Text] [Related]
10. Specificity and frequency of primary anti-HLA cytotoxic T lymphocytes in normal and HLA-B27.2-, HLA-B27.5-, and HLA-Cw3-transgenic mice. A transgenic model for MHC xenoantigen recognition.
Kievits F; Boerenkamp WJ; Lokhorst W; Ivanyi P
J Immunol; 1990 Jun; 144(12):4513-9. PubMed ID: 2351823
[TBL] [Abstract][Full Text] [Related]
11. Monocyte-derived HLA-G acts as a strong inhibitor of autologous CD4 T cell activation and is upregulated by interferon-beta in vitro and in vivo: rationale for the therapy of multiple sclerosis.
Mitsdoerffer M; Schreiner B; Kieseier BC; Neuhaus O; Dichgans J; Hartung HP; Weller M; Wiendl H
J Neuroimmunol; 2005 Feb; 159(1-2):155-64. PubMed ID: 15652415
[TBL] [Abstract][Full Text] [Related]
12. Cytotoxic T cell responses in HLA-A2.1 transgenic mice. Recognition of HLA alloantigens and utilization of HLA-A2.1 as a restriction element.
Le AX; Bernhard EJ; Holterman MJ; Strub S; Parham P; Lacy E; Engelhard VH
J Immunol; 1989 Feb; 142(4):1366-71. PubMed ID: 2464645
[TBL] [Abstract][Full Text] [Related]
13. Cell-mediated graft rejection observed in two lines of human histocompatibility leukocyte antigen class I transgenic mice.
Ando Y; Beck Y; Tomikawa S; Eriguchi M; Muto T; Takiguchi M
Transplantation; 1999 Sep; 68(6):904-8. PubMed ID: 10515394
[TBL] [Abstract][Full Text] [Related]
14. HLA-G in the human placenta: expression and potential functions.
Le Bouteiller P
Biochem Soc Trans; 2000 Feb; 28(2):208-12. PubMed ID: 10816129
[TBL] [Abstract][Full Text] [Related]
15. HLA-G transgenic mice: a model for studying expression and function at the maternal/fetal interface.
Schmidt CM; Orr HT
Immunol Rev; 1995 Oct; 147():53-65. PubMed ID: 8847080
[TBL] [Abstract][Full Text] [Related]
16. Trophoblast class I major histocompatibility complex (MHC) products are resistant to rapid degradation imposed by the human cytomegalovirus (HCMV) gene products US2 and US11.
Schust DJ; Tortorella D; Seebach J; Phan C; Ploegh HL
J Exp Med; 1998 Aug; 188(3):497-503. PubMed ID: 9687527
[TBL] [Abstract][Full Text] [Related]
17. Antigen processing and presentation by human trophoblast-derived cell lines.
Gobin SJ; Wilson L; Keijsers V; Van den Elsen PJ
J Immunol; 1997 Apr; 158(8):3587-92. PubMed ID: 9103419
[TBL] [Abstract][Full Text] [Related]
18. Expression and function of Qa-2 major histocompatibility complex class I molecules in transgenic mice.
Mellor AL; Tomlinson PD; Antoniou J; Chandler P; Robinson P; Felstein M; Sloan J; Edwards A; O'Reilly L; Cooke A
Int Immunol; 1991 May; 3(5):493-502. PubMed ID: 1911536
[TBL] [Abstract][Full Text] [Related]
19. In vitro and in vivo evidence for high frequency of I-Ab-reactive CD4+ T cells in HLA-DQ or HLA-DRA transgenic mice lacking endogenous MHC class I and/or class II expression.
Ishimoto T; Yamamoto K; Fukui Y; Fukuda Y; Dohi K; Sasazuki T
J Immunol; 1997 Oct; 159(8):3717-22. PubMed ID: 9378957
[TBL] [Abstract][Full Text] [Related]
20. Different role of human HLA-DR and -DQ molecules in xenogeneic transplantation using transgenic mice.
Sireci G; Dieli F; Di Sano C; Salerno A
Transplantation; 1999 Jul; 68(2):317-9. PubMed ID: 10440412
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
